Trial Profile
CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Cenderitide (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Proof of concept
- Acronyms BELIEVE III
- 03 Jan 2019 Status changed from recruiting to completed.
- 29 Aug 2016 Planned End Date changed from 1 Jun 2017 to 1 Dec 2016.
- 29 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Oct 2016.